Head-to-head immunogenicity comparison of Edmonston-Zagreb vs. AIK-C measles vaccine strains in infants aged 8–12 months: A randomized clinical trial

Publication date: 29 January 2018
Source:Vaccine, Volume 36, Issue 5
Author(s): Shahrokh Izadi, Seyed Mohsen Zahraei, Masoud Salehi, Mahdi Mohammadi, Seyed Mehdi Tabatabaei, Talat Mokhtari-Azad
BackgroundA non-inferiority multi-centre parallel randomized double-blind trial was implemented in Zahedan district, Sistan-va-Baluchestan province, Iran, to compare the performance of the two measles vaccines which are in use in the National Immunization Programme of Iran and are of two different measles virus vaccine strains: Edmonston-Zagreb (EZ) strain vs. AIK-C strain. The main outcome measure was appearance of anti-measles antibody in sera.Methods200 infants, 8–12 months old, whose parents consented for their children to be included in the study, were randomized in permutation blocks of size 4–8 in four Urban Health Clinics. Having given a pre-vaccination blood sample, they received measles-rubella vaccine containing one of the vaccine strains mentioned before. After 60 days, the second blood sample was taken. The sera of the pre- and post-vaccination blood samples were tested for anti-measles antibodies in the National Reference Measles Laboratory. Parents, laboratory technicians and statistician were blind to groupings.ResultsOf the 200 children equally randomized in the two arms, 185 who were seronegative before vaccination (88 in the EZ arm and 97 in the AIK-C arm) were entered in the final analysis. The seroconversion rate in the EZ arm was 76.1% (95% CI: 60.2–85.2%), and that in the AIK-C arm was 58.7%; (95% CI: 48.8–68.7%). The absolute rate difference was 17. 4% (4.1–30.9%; P-value: .012), and the relative seroconversion rate of EZ to AIK-C was 1.3 (95% CI: 1.1–1.6; P-value: .012). No adverse events were reported during the study period.ConclusionA considerable difference in the seropositivity of different measles containing vaccines could be demonstrated in the first year of life.Trial Registration: Iranian Registry of Clinical Trials Registration Number: IRCT2016032827144N1; May 10, 2016 (http://ift.tt/2mFBuWq)



http://ift.tt/2DqhW2o